164396-36-5Relevant academic research and scientific papers
New N-(phenoxydecyl)phthalimide derivatives displaying potent inhibition activity towards α-glucosidase
Pascale, Rossana,Carocci, Alessia,Catalano, Alessia,Lentini, Giovanni,Spagnoletta, Anna,Cavalluzzi, Maria Maddalena,De Santis, Francesco,De Palma, Annalisa,Scalera, Vito,Franchini, Carlo
experimental part, p. 5903 - 5914 (2010/10/02)
Several members of a new family of non-sugar-type α-glucosidase inhibitors, bearing a phthalimide moiety connected to a variously substituted phenoxy ring by an alkyl chain, were synthesized and their activities were investigated. The efficacy of the inhibition activity appeared to be governed by the chain length of the substrate. Substrates possessing 10 carbons afforded the highest levels of activity, which were one to two orders of magnitude more potent than the known inhibitor 1-deoxynojirimycin (dNM). Furthermore, structure-activity relationship studies indicated a critical role of electron-withdrawing substituents at the phenoxy group for the activity. Derivatives bearing a chlorine atom along with a strong electron-withdrawing group, such as a nitro group, were the most potent of the series.
PREVENTIVE OR THERAPEUTIC DRUGS FOR DIABETES
-
, (2008/06/13)
A composition for use as a preventive or therapeutic agent for diabetes, containing a compound of the formula (I): wherein, A is optionally substituted aryl or optionally substituted heteroaryl; B is lower alkyl, optionally substituted aryl and the like;
